NDAORALCAPSULE
Approved
Jun 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 1w ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MINIZIDE is a fixed-dose combination oral capsule containing polythiazide (a thiazide diuretic) and prazosin hydrochloride (an alpha-1 adrenergic antagonist) approved in 1980 for hypertension management. The combination leverages synergistic mechanisms: prazosin provides vasodilation and alpha-blockade while polythiazide enhances sodium and water excretion, together reducing blood pressure through complementary pathways. This dual-mechanism approach targets patients requiring multi-drug antihypertensive therapy.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), the brand team is likely in defensive/maintenance mode focused on retention and cost management rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings signal minimal hiring or career mobility on MINIZIDE; this is a maintenance-phase product with stable but limited headcount. Professionals assigned to this brand should expect focus on cost containment, market defense, and transition planning rather than growth opportunities.
Brand ManagerField Sales Representative
Worked on MINIZIDE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.